BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nannini G, Meoni G, Amedei A, Tenori L. Metabolomics profile in gastrointestinal cancers: Update and future perspectives. World J Gastroenterol 2020; 26(20): 2514-2532 [PMID: 32523308 DOI: 10.3748/wjg.v26.i20.2514] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui MY, Yi X, Zhu DX, Wu J. Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review. Transl Cancer Res 2021;10:3829-42. [PMID: 35116681 DOI: 10.21037/tcr-21-655] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vignoli A, Risi E, McCartney A, Migliaccio I, Moretti E, Malorni L, Luchinat C, Biganzoli L, Tenori L. Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer. Int J Mol Sci 2021;22:4687. [PMID: 33925233 DOI: 10.3390/ijms22094687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Michálková L, Horník Š, Sýkora J, Habartová L, Setnička V, Bunganič B. Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. J Proteome Res 2021;20:1744-53. [PMID: 33617266 DOI: 10.1021/acs.jproteome.0c00990] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Eroglu EC, Tunug S, Geckil OF, Gulec UK, Vardar MA, Paydas S. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS. Eur J Mass Spectrom (Chichester) 2021;:14690667211057996. [PMID: 34806450 DOI: 10.1177/14690667211057996] [Reference Citation Analysis]
5 Alorda-clara M, Torrens-mas M, Morla-barcelo PM, Martinez-bernabe T, Sastre-serra J, Roca P, Pons DG, Oliver J, Reyes J. Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers. Cancers 2022;14:817. [DOI: 10.3390/cancers14030817] [Reference Citation Analysis]
6 Citterio F, Romano F, Meoni G, Iaderosa G, Grossi S, Sobrero A, Dego F, Corana M, Berta GN, Tenori L, Aimetti M. Changes in the Salivary Metabolic Profile of Generalized Periodontitis Patients after Non-surgical Periodontal Therapy: A Metabolomic Analysis Using Nuclear Magnetic Resonance Spectroscopy. J Clin Med 2020;9:E3977. [PMID: 33302593 DOI: 10.3390/jcm9123977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Di Donato S, Vignoli A, Biagioni C, Malorni L, Mori E, Tenori L, Calamai V, Parnofiello A, Di Pierro G, Migliaccio I, Cantafio S, Baraghini M, Mottino G, Becheri D, Del Monte F, Miceli E, McCartney A, Di Leo A, Luchinat C, Biganzoli L. A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting. Cancers (Basel) 2021;13:2762. [PMID: 34199435 DOI: 10.3390/cancers13112762] [Reference Citation Analysis]
8 Wang W, Han Z, Guo D, Xiang Y. UHPLC-QTOFMS-based metabolomic analysis of serum and urine in rats treated with musalais containing varying ethyl carbamate content. Anal Bioanal Chem 2020;412:7627-37. [PMID: 32897411 DOI: 10.1007/s00216-020-02900-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Petrov MS. Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer. World J Gastroenterol 2021; 27(17): 1936-1942 [PMID: 34007131 DOI: 10.3748/wjg.v27.i17.1936] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nannini G, Meoni G, Tenori L, Ringressi MN, Taddei A, Niccolai E, Baldi S, Russo E, Luchinat C, Amedei A. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps. World J Gastroenterol 2021; 27(38): 6430-6441 [PMID: 34720532 DOI: 10.3748/wjg.v27.i38.6430] [Reference Citation Analysis]
11 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Reference Citation Analysis]
12 Troisi J, Tafuro M, Lombardi M, Scala G, Richards SM, Symes SJK, Ascierto PA, Delrio P, Tatangelo F, Buonerba C, Pierri B, Cerino P. A Metabolomics-Based Screening Proposal for Colorectal Cancer. Metabolites 2022;12:110. [DOI: 10.3390/metabo12020110] [Reference Citation Analysis]